A PET study examining pharmacokinetics and dopamine transporter receptor occupancy of repeat dosing of OROS methylphenidate (CONCERTA) and immediate release methylphenidate in healthy adults.

Trial Profile

A PET study examining pharmacokinetics and dopamine transporter receptor occupancy of repeat dosing of OROS methylphenidate (CONCERTA) and immediate release methylphenidate in healthy adults.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Oct 2013

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 21 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jul 2013 Planned end date changed from 1 Apr 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 01 Nov 2012 Planned End Date changed from 1 Apr 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top